Quotient Receives FDA License to Sell a Range of Rare Polyclonal Antisera Products in the USA

NEWTOWN, PA., October 2nd, 2012 – Quotient Biodiagnostics, Inc. (“Quotient”), a supplier of innovative and high-quality transfusion diagnostic products to hospitals, blood banks and other healthcare institutions, is pleased to announce that its range of ALBAsera® Rare Antisera products have been licensed for sale by the U.S. Food and Drug Administration (FDA).

Get Answers Here